Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2025-02-12 Earnings Release
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update.pdf
Earnings Release Classification · 100% confidence The document explicitly states in the headline and opening paragraph that it reports 'Full Year 2024 Results' and provides a 'Fourth Quarter Business Update'. It contains detailed financial figures for the full year 2024 (e.g., Total net revenues, R&D expenses) presented in a table format, alongside extensive operational updates on clinical trials and strategic reorganization (the planned spin-off). This combination of comprehensive annual financial reporting and detailed operational review strongly indicates an Annual Report or a document closely associated with it. Since the text is a press release format announcing the results, it is most accurately classified as an Earnings Release (ER) if it were only quarterly highlights, or an Interim Report (IR) if it were a comprehensive half-year report. However, because it covers the *Full Year* results and is highly detailed, it functions as the primary communication of the annual performance, which aligns best with the scope of a 10-K, even if this specific text is the press release version. Given the options, and the comprehensive nature covering the entire fiscal year's performance and outlook, it is the primary communication of the annual results. If a 10-K were available, this would be the ER preceding it, but since it covers the full year, ER is too narrow. The closest fit for a comprehensive annual financial disclosure announcement is often treated as the primary communication of the Annual Report data, but following strict definitions, a press release detailing full-year results is typically an Earnings Release (ER) or sometimes an Interim Report (IR) if it's not the final 10-K filing. Given the depth and the 'Full Year' focus, it contains the core information that would populate a 10-K. However, the structure is that of a press release announcing results, which is the definition of an Earnings Release (ER). Since it covers the *full year*, it is more comprehensive than a standard quarterly ER. In many databases, the press release announcing the full-year results is categorized as ER, while the formal 10-K filing is 10-K. Given the content is the announcement itself, ER is the most appropriate classification for this specific document type (press release announcing results). FY 2024
2025-02-12 English
Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft een business update over het vierde kwartaal.pdf
Earnings Release Classification · 100% confidence The document is titled "Galapagos rapporteert resultaten over het gehele jaar 2024 en geeft een business update over het vierde kwartaal" (Galapagos reports full-year 2024 results and provides a Q4 business update). It contains detailed financial highlights for the full year 2024, clinical trial data updates (GLPG5101, GLPG5301), strategic updates (plan to split into two companies), and mentions an upcoming conference call. The content is comprehensive, covering financial performance, operational updates, and future outlook for the entire fiscal year, which strongly indicates an Annual Report or a document closely associated with it, like a detailed Earnings Release that incorporates annual figures. However, the structure and depth, especially covering the full year's results and strategic direction, align best with the scope of an Annual Report (10-K) or a very detailed Earnings Release (ER) that serves as the primary annual disclosure. Given the Dutch language and the context of corporate reporting, this is likely the primary annual financial disclosure document, even if it's presented as a press release summarizing the 10-K contents. Since it explicitly reports 'resultaten over het gehele jaar 2024' (full-year results) and includes extensive operational and financial details, it is classified as an Earnings Release (ER) which typically precedes or summarizes the 10-K filing, or an Interim Report (IR) if it were only for a shorter period. Since it covers the *entire year* and includes management commentary and detailed pipeline updates, it functions as the primary annual financial disclosure announcement. In many contexts, a detailed press release announcing full-year results is categorized as an Earnings Release (ER). If this were the actual 10-K filing, the code would be 10-K. Since it is a press release announcing these results and includes a link to a conference call, ER is the most appropriate fit among the provided options for a comprehensive annual results announcement that isn't the formal 10-K filing itself. FY 2024
2025-02-12 Dutch
6-K Filing
Regulatory Filings
2025-02-12 English
Galapagos presenteert op de 43ste jaarlijkse J.P. Morgan Healthcare Conference
Investor Presentation Classification · 95% confidence The document is a press release announcing that Galapagos management will present at the 43rd Annual J.P. Morgan Healthcare Conference on a specific date. This type of announcement, which informs investors about participation in a major industry event (like a conference presentation), is typically classified as an Investor Presentation (IP) announcement or, more broadly, a general regulatory/investor relations communication. Since the document itself is an announcement about a future presentation, and not the presentation slides or the transcript of the presentation, it fits best under the category for investor-focused communications that aren't formal financial reports. Given the options, 'Investor Presentation' (IP) is the most relevant category for an announcement regarding participation in a major investor conference, even though the actual presentation material is not included here. However, if the document is short and primarily serves to announce the event and provide webcast details, it could also be considered a general Regulatory Filing (RNS) or a Report Publication Announcement (RPA) if it were announcing the release of a document. Since it is announcing participation in a specific investor event, IP is the strongest fit, representing the subject matter being communicated to investors.
2025-01-08 English
Galapagos presenteert op de 43ste jaarlijkse J.P. Morgan Healthcare Conference
Investor Presentation Classification · 99% confidence The document is a press release announcing that Galapagos NV will be presenting at the 43rd annual J.P. Morgan Healthcare Conference on January 15, 2025. It also mentions a separate breakfast meeting for analysts on January 14, 2025. This type of announcement, detailing participation in an external industry conference where management will present company updates, is best classified as an Investor Presentation (IP) announcement or material related to investor engagement, but since the core purpose is announcing the presentation itself, it aligns closely with materials shared during investor events. However, looking at the definitions, it is not a full presentation (IP), nor is it a formal regulatory filing (10-K, IR, ER). It is an announcement about an upcoming investor event. Given the options, this is a specific type of corporate communication aimed at investors regarding an upcoming presentation. Since there isn't a specific 'Conference Presentation Announcement' code, and it is not a full transcript (CT) or a formal earnings release (ER), the closest fit among the provided options that relates to investor engagement and presentations is 'Investor Presentation' (IP), although it is an announcement *about* one. Alternatively, it could be a general 'Regulatory Filing' (RNS) if it were purely informational, but the content is highly focused on investor relations activities. Given the context of presenting at a major healthcare conference, 'Investor Presentation' (IP) is the most contextually relevant category for the *subject matter* being announced, even if the document itself is the announcement.
2025-01-08 Dutch
Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
Regulatory Filings Classification · 100% confidence The document is a press release dated January 8, 2025, announcing a major corporate action: the planned split of Galapagos NV into two publicly traded entities (Galapagos and 'SpinCo'). It details the rationale, the financial implications (SpinCo capitalization, Gilead agreement changes), the expected timeline (mid-2025), and mentions an upcoming conference call. This announcement concerns a significant change in the company's capital structure and corporate organization, specifically a spin-off. While it involves capital structure changes (CAP) and management strategy (MDA), the core event is the proposed split/reorganization which results in a new share issuance/structure for the new entity. The most fitting category for a major corporate restructuring involving the creation of a new entity and subsequent share distribution is 'Share Issue/Capital Change' (SHA), as the spin-off results in shareholders receiving shares in the new company on a pro-rata basis. It is not a standard Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). Since it explicitly details the mechanism of distributing shares of the new entity to existing shareholders, SHA is the best fit over CAP, which is usually for fundraising/debt issuance.
2025-01-08 Dutch

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.